Top 10 Drug Delivery Device Companies
In recent years, greater emphasis is being put on developing innovative and effective ways of drug delivery systems. As per a Massachusetts-based market research firm, the drug delivery market will increase to $227.3 billion in 2020. This emphasis becomes crucial as even the drugs developed with the most advanced biology strategies can have probable side-effects due to their interaction with healthy tissue. Therefore, there are constant efforts to design delivery systems that administer medicine to only the targeted cells and leaving healthy tissues.
Check This Out: Med Tech outlook
Constant research in drug delivery systems has led to the emergence of some marvelous innovations. Self-Emulsifying Drug Delivery Systems(SEDDS) provide significant aid in administering poorly soluble drugs orally. These systems also significantly improve the bioavailability of the drugs that are applied.
Such innovations have led to an influx of enterprises in the market that provide the most efficient forms of drug delivery techniques for better patient healthcare. To help hospitals and health institutions select the organization best suited for their needs, we at MedTech Outlook present “Top 10 Drug Delivery Device Companies — 2019.”
Top Drug Delivery Device Companies
BetterLife Pharma
BetterLife Pharma Pharmaceuticals is poised to become a strategic winner in this exploding market. BetterLife Pharma is on a mission to capitalize key cannabis markets in Canada, United States, and the European Union. In combination with a solid merger and acquisition strategy, the organization strives to become a leader in the pharmaceutical, OTC, nutraceutical and wellness markets. BetterLife Pharma adds value to products in the nutraceutical, OTC, and medical wellness market using patent protected drug delivery technologies
Check This Out: betterlifepharma.com
Nanoshell Company
Nanoshell’s technology can also be used to selectively target and extract cells from the blood that are associated with different diseases such as cancer, as well as toxins, and viruses by using various nanomaterials. The company’s Intelligent NanoDelivery System also enhances the effectiveness and aesthetics of actives in cosmetics and personal care products. Its nanosized delivery vehicles can penetrate into selected depths of the skin or the hair cuticle to deliver beneficial substances that truly support its repair, regeneration, and protection.Nanoshell’s nanobiotechnology-enabled system for continuous blood purification and cancer therapeutics was awarded the TechConnect Defense Innovation Award in 2018
Check This Out: www.nanoshellcompany.com
QualiMed
The company is focused on three areas of intervention: Interventional Cardiology, Peripheral Vascular, and Non-Vascular applications.. To continually innovate, QualiMed augments its team with talented individuals that like the evolutionary change that the company is bringing to the market from its biodegradable, micro-invasive, and localized drug delivery technologies. QualiMed’s people, coupled with the clinicians and patients, deserve a better standard of care and have that opportunity to deliver this through its innovative platforms. QualiMed differentiates itself by developing a localized delivery tool to increase the localized penetration of the drug or therapy
Check This Out: qualimed.de
Quantex Arc
The company supplies single-use pumps and also provide a design and development service for custom applications. Their engineers and designers are on hand to provide design expertise throughout the development programme and assistance into volume production.The single-use Quantex pump provides accurate dispensing at low cost. The pump can be part of the packaging and is disposed of at the end of the liquid pack. The high precision and functionality of the pump allows it to be used in a wide range of markets including medical, pharmaceutical, food, beverage, consumer and industrial. Quantex produce a range of ‘off-the-shelf’ pumps. They also provide a custom pump design service. This allows to incorporate a pump that only works with user’s dispenser.They also provide custom fittings and custom pumps and typical dispense systems.
Check This Out: www.quantex-arc.com
Avro Life Science
Avro is a leading preclinical stage pharmaceutical company developing OmniDerm(™) — a platform transdermal technology for the passive delivery of small drug molecules. Avro’s novel polymer utilizes cutting-edge advances in biomaterials engineering and micro-encapsulation technology, to hold and deliver a wide range of drugs over a 1–7 day timespan, where transdermal delivery was previously thought to be impossible. Their mission is to improve patient health outcomes and quality of life through medication compliance and adherence afforded by effective drug delivery solutions
Becton Dickinson
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD and its employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care
Consort Medical
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
